PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Phenotype | |cirrhosis |
| Sentences | 171 |
| PubMedID- 26215124 | The aim of this study was to characterize the immune status of hcv-related cirrhosis in patients with hepatocellular carcinoma (hcv-hcc) as compared to hcv patients without hepatocellular carcinoma. |
| PubMedID- 21224679 | Treatment for hepatocellular carcinoma (hcc) with advanced cirrhosis, especially with hypersplenic thrombocytopenia, will be very difficult. |
| PubMedID- 23732780 | Influence of etiology on host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma receiving intra-arterial chemotherapy. |
| PubMedID- 21247464 | An estimated 3% of the world's population (270 million people) is chronically infected by hcv which is the main cause of liver fibrosis and cirrhosis that leads to hepatocellular carcinoma (hcc) in a significant number of patients [1,2]. |
| PubMedID- 23825904 | Material and methods: thirty-five cases each of chronic hcv hepatitis type 4 (group i) and cirrhosis with hepatocellular carcinoma (hcc) complicating chronic hcv hepatitis (groups ii and iii) were immunohistochemically evaluated using a p21 ras polyclonal antibody. |
| PubMedID- 24949326 | We recently experienced a case of ldlt for hepatocellular carcinoma combined with liver cirrhosis secondary to hepatitis b virus and hepatitis c virus infection. |
| PubMedID- 19762191 | So far, the available data suggest that iron accumulation in the liver is an independent risk factor for hepatocellular carcinoma in patients with alcoholic cirrhosis and/or nonalcoholic hepatosteatosis, but not in those with viral hepatitis c cirrhosis. |
| PubMedID- 26273598 | Simple steatosis, or fatty liver, occurs early in nafld and may progress to nonalcoholic steatohepatitis (nash), fibrosis, and cirrhosis with increased risk of hepatocellular carcinoma [5–7]. |
| PubMedID- 26442209 | Between 60 and 90% of hepatocellular carcinoma occur in patients with hepatic macronodular cirrhosis (18, 19). |
| PubMedID- 21331263 | Patients can evolve from chronic hepatitis directly to hepatocellular carcinoma without first developing cirrhosis, especially those with genotype 1b [5]. |
| PubMedID- 26017364 | The indications for lt were hepatocellular carcinoma with viral cirrhosis (n = 15), cirrhosis secondary to viral etiology (2), and alcoholic cirrhosis (2). |
| PubMedID- 20071115 | The first case was a 58-year-old man transplanted for cirrhosis complicated by hepatocellular carcinoma. |
| PubMedID- 25702281 | Serum paraoxonase 1 (pon1) is highly fucosylated in hepatocellular carcinoma (hcc) compared with liver cirrhosis (lc). |
| PubMedID- 25513088 | As hepatocellular carcinoma is often associated with liver cirrhosis, patients are at risk for postoperative liver failure. |
| PubMedID- 23769079 | The most common primary diseases was hepatitis b virus-related liver cirrhosis with or without hepatocellular carcinoma (64.3%). |
| PubMedID- 20001440 | Background: squamous cell carcinoma antigen-immunoglobulin m (scca-igm) is a useful biomarker for the risk of development of hepatocellular carcinoma (hcc) in patients with cirrhosis due to its progressive increase associated to hcc evolution. |
| PubMedID- 25714713 | Finally, the higher induction of egr1 related to genotype 3a is of interest in that it has been identified recently as a molecular marker for the development of hepatocellular carcinoma in patients with hcv-related cirrhosis (19); moreover, ipa predicted inhibition of mirna-154 and mirna-25, both recently linked with suppression of cancer cell growth (39–41). |
| PubMedID- 20831903 | Background & aims: there are few data available about the prevalence or effects of cirrhosis in patients with hepatocellular carcinoma (hcc) from viral hepatitis. |
| PubMedID- 24223226 | Furthermore, bcaa supplementation has been suggested to prevent the incidence of hepatocellular carcinoma in patients with liver cirrhosis [5]–[7]. |
| PubMedID- 23479099 | Prognosis and predictors of surgical complications in hepatocellular carcinoma patients with or without cirrhosis after hepatectomy. |
| PubMedID- 22923953 | [11] association between chronic alcohol abuse, cirrhosis, and the development of hepatocellular carcinoma (hcc) is well documented. |
| PubMedID- 23708326 | Branched-chain amino acids (bcaas) reportedly inhibit the incidence of hepatocellular carcinoma (hcc) in patients with liver cirrhosis and obesity that is frequently associated with insulin resistance (ir). |
| PubMedID- 24634946 | Background/aims: type b and c hepatic cirrhosis are main causes of hepatocellular carcinoma (hcc). |
| PubMedID- 22723858 | Besides emphysema, the z aat variant also predisposes to liver diseases, which may present in zz homozygous individuals as neonatal jaundice, cirrhosis and increased risk of hepatocellular carcinoma [7]. |
| PubMedID- 23000435 | We report the case and discuss the outcome of a 63-year-old man, who was transplanted for hepatocellular carcinoma arising from cirrhosis associated with non-alcoholic fatty liver and diabetes. |
| PubMedID- 26042593 | Nash is characterized by steatosis, inflammation, hepatocyte death and at later stages fibrosis, cirrhosis, and the development of hepatocellular carcinoma (hcc) [5]. |
| PubMedID- 25969676 | Two more cases with smh were reported, however one had hepatocellular carcinoma as the cause of cirrhosis and the other one had alpha-1 antitrypsin deficiency as the cause of cirrhosis. |
| PubMedID- 20845516 | Aim: to determine the role of diabetes mellitus (dm) and other associated factors in chinese hepatocellular carcinoma (hcc) patients with cirrhosis, compared with those hcc patients without cirrhosis, in the single setting of hepatitis b virus (hbv) infection, after other known concomitant diseases were excluded. |
| PubMedID- 25894142 | Conclusions: patients transplanted for hepatitis b and d virus cirrhosis, even with hepatocellular carcinoma, had favorable prognosis and good longterm results. |
| PubMedID- 20012230 | Methods: in this study, we enrolled 20 patients having liver cirrhosis with hepatocellular carcinoma and randomly assigned them into two groups to receive autologous stem cells or placebo. |
| PubMedID- 26223866 | In the case of hbv, 5 % of adults exposed to the virus develop chronic hbv infection, and cirrhosis and death because of hepatocellular carcinoma are important complications of chronic hbv infection [10, 11]. |
| PubMedID- 23431294 | Simple steatosis, or fatty liver, occurs early in nafld and may progress to nonalcoholic steatohepatitis (nash), fibrosis, and cirrhosis with increased risk of hepatocellular carcinoma [1, 3]. |
| PubMedID- 21188198 | Chronic hepatitis c is a major cause of chronic liver disease globally, and the natural history of progression may lead to cirrhosis with liver failure, hepatocellular carcinoma, and premature liver-related death. |
| PubMedID- 25330059 | Liver resection for hepatocellular carcinoma (hcc) combined with nash-related cirrhosis has become increasingly common. |
| PubMedID- 21689619 | While initially performed only for benign hepatic lesions, the indications for laparoscopic resection have gradually broadened to encompass all kinds of malignant hepatic lesions, including hepatocellular carcinoma in patients with cirrhosis, for whom the advantages of the minimally invasive approach may be most evident. |
| PubMedID- 21528069 | Intraductal papillary neoplasm of the bile duct in liver cirrhosis with hepatocellular carcinoma. |
| PubMedID- 23710205 | Mostly chronic hepatitis c virus has a uniform natural history, from liver cirrhosis to the development of hepatocellular carcinoma. |
| PubMedID- 21695929 | Its efficacy was shown in the sharp study that enabled licensing of sorafenib for the therapy of inoperable, metastasizing hepatocellular carcinoma, including patients with liver cirrhosis, functional class child-pugh a or b, in more than 60 countries worldwide, including the czech republic. |
| PubMedID- 23519837 | Purpose: detection, characterization, and monitoring the treatment of hepatocellular carcinomas (hcc) in patients with cirrhosis is challenging because of their variable and rapid arterial enhancement. |
| PubMedID- 25524812 | Background & aims: surveillance for hepatocellular carcinoma (hcc) in patients with cirrhosis is recommended in clinical guidelines. |
| PubMedID- 20170495 | Hcv infection causes chronic liver disease, cirrhosis, and is associated with hepatocellular carcinoma [2]. |
| PubMedID- 23423240 | Portal vein thrombosis (pvt) is commonly associated with liver cirrhosis, irrespective of the presence of hepatocellular carcinoma (hcc). |
| PubMedID- 21371325 | Background: occult hbv infection accelerates the progression of liver fibrosis, cirrhosis, and finally leading to hepatocellular carcinoma (hcc). |
| PubMedID- 21520172 | For patients who have cirrhosis with hepatocellular carcinoma (hcc), living donor liver transplantation (ldlt) reduces waiting time and dropout rates. |
| PubMedID- 23530966 | Results: more than half of the patients had cirrhosis with hepatocellular carcinoma. |
| PubMedID- 23396727 | cirrhosis co-exists with hepatocellular carcinoma in about 60% of patients and is equally common in the two sexes. |
| PubMedID- 23304671 | Hbv subgenotype c2 infection, a1762t/g1764a mutations may contribute to hepatocellular carcinoma with cirrhosis in southeast china. |
| PubMedID- 23320019 | In two studies performed on mrcc patients or liver cirrhosis patients with advanced hepatocellular carcinoma treated with sorafenib, no impact on th1 response has been observed [42, 44]. |
| PubMedID- 25963509 | New evidence shows that statins improve response to interferon-based anti-hcv therapy, decrease progression to cirrhosis and likelihood of developing hepatocellular carcinoma. |
| PubMedID- 23164412 | It was shown [6] that oral antiviral therapy reduces the risk of hepatocellular carcinoma only in patients without cirrhosis, but could not protect patients with chronic infection. |